UBT251 Injection Phase II Study (Overweight or Obesity)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This randomized, double-blind, parallel, placebo-controlled phase II study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients
Epistemonikos ID: c4122e1fb12ce2cd38d1a03c01bdd1c77601eacd
First added on: Sep 18, 2025